Top compounds associated with response to CHD2


Feature Type Standardized
Nominal ANOVA
mRNA Sorafenib CCLE pan-cancer AAC 0.00027 1
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.00012 1
mRNA Tamoxifen GDSC1000 pan-cancer AAC -6.3e-05 1
mRNA CAY10618 CTRPv2 pan-cancer AAC 3.9e-05 1
Download CSV